Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 13, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,211	1,267	2,384	2,459	2,338	2,274
Market Cap Growth	-14.47%	-46.88%	-3.03%	5.18%	2.82%	20.13%
Enterprise Value	1,287	1,338	2,456	2,530	2,392	2,285
Last Close Price	13.00	13.55	25.34	25.90	24.41	23.56

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 13, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	25.05	18.94	28.39	24.93	23.97	20.02
PS Ratio	2.64	2.53	4.17	4.41	4.41	4.51
PB Ratio	0.78	0.83	1.62	1.76	1.78	1.84
P/TBV Ratio	0.78	0.83	1.62	1.76	1.78	1.84
P/FCF Ratio	4806.05	61.59	182.32	958.68	-	-
P/OCF Ratio	28.39	11.04	13.61	11.98	13.02	12.60

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 13, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
EV/Sales Ratio	2.81	2.67	4.30	4.53	4.51	4.54
EV/EBITDA Ratio	9.55	8.46	11.83	13.05	13.66	13.09
EV/EBIT Ratio	17.97	13.99	17.34	18.69	17.93	16.75
EV/FCF Ratio	5110.72	65.04	187.80	986.61	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 13, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.05
Debt / EBITDA Ratio	0.58	0.48	0.37	0.37	0.36	0.34
Debt / FCF Ratio	308.24	3.69	5.81	27.92	-	-
Net Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.01
Net Debt / EBITDA Ratio	0.57	0.47	0.35	0.36	0.34	0.10
Net Debt / FCF Ratio	304.68	3.60	5.51	27.50	-5.16	-4.69
Asset Turnover	0.24	0.26	0.31	0.33	0.34	0.35
Inventory Turnover	4.17	4.87	4.68	4.16	3.96	4.01
Quick Ratio	1.27	1.01	0.78	0.62	0.71	1.03
Current Ratio	1.81	1.51	1.28	1.15	1.38	1.72
Return on Equity (ROE)	3.13%	4.46%	5.85%	7.27%	7.66%	9.65%
Return on Assets (ROA)	2.30%	3.15%	4.86%	4.93%	5.27%	5.90%
Return on Invested Capital (ROIC)	3.41%	4.71%	7.61%	7.30%	7.61%	9.73%
Return on Capital Employed (ROCE)	4.00%	5.50%	8.50%	8.60%	9.00%	10.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 13, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Earnings Yield	3.97%	5.28%	3.52%	4.01%	4.17%	5.00%
FCF Yield	0.02%	1.62%	0.55%	0.10%	-0.49%	-0.16%
Dividend Yield	0.39%	0.37%	0.40%	0.77%	0.82%	0.83%
Payout Ratio	4.29%	22.06%	9.76%	8.93%	22.79%	7.11%
Total Shareholder Return	1.01%	0.37%	0.40%	0.77%	0.82%	0.83%

Data Source: S&P Global Market Intelligence Last updated: May 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 11, 2026

Data Sources Report a data error